Levulan 01
Levulan Kerastick Kit
Product Images NDC 67308-101
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Levulan Kerastick (NDC 67308-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Levulan 02
Levulan 03
Levulan 04
Levulan 05
Levulan 06
The text provides a graph (Figure 4) showing the percentage of subjects (N=110) who achieved complete response, that is, 100% clearance of treated lesions, over the course of several months.*
Levulan 07
Levulan 08
The text describes the enrollment and treatment of 269 individuals using Levulan light and Vehicle/light in weeks 0 and 8. There are not clear results for some patients in week 8, and some patients were retreated in week 12. The number of patients with clear and not clear results is listed for each treatment group and time point.*
Levulan 09
Levulan 10
Levulan 11
The text appears to be a description of a medication called "LEVULAN KERASTICK®". The medication is a topical solution containing 4 (aminolevulinic acid HC). However, the description does not provide any information on what the medication is used for or how to administer it.*
Levulan 12
Levulan 13
Levulan 14
LEVULAN" KERASTICK is a 20% topical solution of aminolevulinic acid HCI for a single user. The rest of the text is not readable.*
Levulan 15
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
